INTRODUCTION
Sjögren's syndrome (SS) is an autoimmune disease of B-cell hyperactivity, which is reflected by pathogenic autoantibody production. B-cell Ab production requires help from T cells. + T cells that have migrated into B-cell follicles of secondary lymphoid organs in order to participate in germinal center (GC) reactions (1) . Tfh cells stimulate B cells to produce high-affinity Abs through affinity maturation and class switch recombination within the GC. IL-21, a cytokine produced by Tfh cells, works as a signal for B-cell maturation and differentiation (2) . The interaction between Tfh cells and B cells, in concert with IL-21, may play a crucial role in SS pathogenesis (3) (4) (5) (6) .
Follicular regulatory T (Tfr) cells, a recently discovered subset of Tregs, regulate GC reactions (7) (8) (9) . Tfr cells are derived from thymic Treg cells and gain access to the GC (7) (8) (9) . Tfr cells share a phenotype with Tfh cells: Tfr cells express surface markers of CXCR5, inducible costimulator (ICOS), and PD-1, and transcriptional factor Bcl-6 (10) . CXCR5 + CD4 + T cells may contain both Tfh and Tfr cells, despite their different functions on GC B cells. Since the SS represents a dysregulated GC response, the characteristics of Tfh and Tfr cells need explored in SS. Several studies have investigated the Tfh and Tfr cell populations in peripheral blood of SS; however, little is currently known about Tfr cells in SS (11) (12) (13) .
Circulating Tfr and Tfh cells are a distinct subset differing from Tfr and Tfh cells found in secondary lymphoid tissues. Notably, circulating Tfr and Tfh cells develop independently to have memory cell properties (14) . Blood Tfr and Tfh cells circulate until they become fully activated and enter the GC (14) . Due to challenges in obtaining cells from human secondary lymphoid tissues, circulating Tfr cells and Tfh cells are used in human studies as counterparts to Tfr and Tfh cells from lymphoid tissues (15) (16) (17) (18) . Studies have investigated that specific subsets of circulating CXCR5 + CD4 + T cells are Tfh cell precursors, which can enter the GC and support B-cell response (19-21). He and colleagues had found that the CCR7 lo PD-1 hi subset of circulating CXCR5 + CD4 + T cells differentiate into mature Tfh cells and promote GC responses in mice and humans. Thus, this subset indicates active Tfh cell differentiation in secondary lymphoid organs (21). In addition, the CCR7 lo PD-1 hi subset was expanded in patients with systemic lupus erythematosus (SLE) or rheumatoid arthritis and was correlated with disease activity scores and autoantibody titers (21).
We examined circulating Tfr and Tfh cell populations and their ratios in patients with primary Sjögren's syndrome (pSS). In addition, we examined the specific subsets of circulating Tfr and Tfh cell populations, with a focus on the CCR7 lo PD-1 hi subset and the Th1-like, Th2-like, or Th17-like subsets. Association of circulating Tfr and Tfh cells and their specific subsets with SS disease activity, target organ inflammation, autoantibody responses, and IL-21 secretion were also investigated. The CCR7 lo PD-1 hi subset of circulating Tfh cells may be used as a biomarker for disease activity and glandular inflammation, and blood Tfr cell subsets may be used as an indicator of IgG production in patients with pSS.
MATERIALS AND METHODS

Study population and human blood samples
Patients with pSS (n=18) who fulfilled the 2016 American College of Rheumatology/ European League Against Rheumatism Classification Criteria for pSS (22) and healthy control individuals (n=14) were recruited for this study. The mean age of the pSS patients and healthy controls (HCs) were 51.7 and 48.3 years (p>0.05), respectively. All study participants were women (Supplementary Table 1) . Peripheral blood was collected from patients with pSS and HCs. Heparinized blood (10 ml) and serum samples were obtained from each study participant. Informed consent was obtained from the study participants. This study was approved by the Ethics Committee of Seoul St. Mary's Hospital, The Catholic University of Korea (approval ID: KC12TISI0501). All study procedures were performed according to the Declaration of Helsinki.
Clinical and immunological variables of study population
Data on disease duration, European League Against Rheumatism Sjögren's Syndrome Disease Activity Index (ESSDAI), and focus scores of labial salivary gland (LSG) biopsies, along with levels of serum rheumatoid factor (RF), anti-Sjögren's-syndrome-related antigen A (anti-SSA)/Ro Abs, IgG, were collected at the time of blood sampling. Patients with pSS had a median disease duration of 3.6 months and a median ESSDAI score of 2 (Supplementary Table 1 ). Ninety-two percent of the 12 SS patients who underwent LSG biopsy showed focus scores (FSs) of >1. Patients with SS did not take any disease-modifying antirheumatic drugs other than hydroxychloroquine or predinisolone equivalent > 5 mg per day. 
PBMC isolation and flow cytometry
ELISA
Serum IL-21 was measured using the Human IL-21 ELISA MAX Deluxe kit (BioLegend) according to the manufacturer's instruction.
Statistical analysis
Data were compared between 2 (or 3) independent groups using an independent t-test (or 1-way ANOVA with post-hoc Bonferroni test) for continuous variables. An independent t-test with Welch's correction was used when the variance was not equal between groups. Results were expressed as the mean±SEM. Spearman's correlation analysis was performed to determine the correlation of Tfr cells, Tfh cells, and their respective subsets with SS clinical and immunological variables. GraphPad Prism version 5 (GraphPad Software, San Diego, CA, USA) was used to make graphs and perform statistical analysis. A heatmap image for correlation was drawn using the "corrplot" package from R software 3.5.1 (R Project, Vienna, Austria). The p values <0.05 were considered statistically significant. 1A) and compared between pSS patients and HCs (Fig. 1B) . Blood Tfr cells tended to increase in patients with pSS, whereas blood Tfh cells did not differ between pSS patients and HCs. Blood Tfr and Tfh cell ratios were significantly elevated in patients with pSS compared to HCs (p<0.05, Fig. 1C ).
RESULTS
Tfh and Tfr cells and their ratios in peripheral blood of SS patients
To examine the differentiation of B cell subsets in peripheral blood, circulating plasmablasts and plasma cells were identified from flow cytometry analysis (Supplementary Fig. 1A ). 
PD-1 expression on Tfh and Tfr cells in peripheral blood and correlations with serum IL-21 and autoantibody levels
Since PD-1 and ICOS are activation markers of T cells, we examined their expression on Tfh and Tfr cells in peripheral blood of pSS patients and HCs. Mean fluorescence intensity (MFI) of PD-1 expression on blood Tfh and Tfr cells was increased in pSS patients, but was not statistically significant ( Fig. 2A) . Serum IL-21 levels were markedly increased in pSS patients compared to HCs (Fig. 2B) . We examined whether PD-1 and ICOS expression on blood Tfh and Tfr cells may represent disease indices of SS. PD-1 expression on Tfh and Tfr cells in peripheral blood was significantly correlated with serum IL-21 levels (Fig. 2C) . Although it was not significant, PD-1 expression on Tfh and Tfr cells showed positive correlations with anti-SSA/Ro and RF titers (Supplementary Fig. 2 ). In contrast, ICOS expression on Tfh and Tfr cells showed negative or negligible correlations with serum IL-21 levels and autoantibody titers in SS (Supplementary Fig. 3 + T cells shift to populations expressing low amounts of CCR7 and high amounts of PD-1 in pSS patients (data not shown). The CCR7 lo PD-1 hi subset of circulating Tfh cells tended to increase in pSS patients, but was not statistically significant (Fig. 3B) . To determine whether these blood Tfh and Tfr cell subsets are affected by lymphocytic infiltration in salivary gland tissue, patients with pSS were divided into 
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ρ . p= . (Fig. 3C) . The CCR7 lo PD-1 hi subset of blood Tfr cells did not show any difference between pSS patients and HCs (Fig. 3D) . Next, we examined the correlation of blood Tfh and Tfr cells and their subsets with disease activity, blood B-cell subsets, serum autoantibody titers, serum IgG levels, and serum IL-21 levels in pSS (Fig. 3E) . Notably, the CCR7 lo PD-1 hi subset of blood Tfh cells was correlated with ESSDAI (ρ=0.552, p=0.018) (Fig. 3F) . The CCR7 lo PD-1 hi subset of blood Tfh cells showed a significant correlation with blood plasma cells (Fig. 3G) . In short, the CCR7 lo PD-1 hi subset, and not the CCR7 hi PD-1 lo subset, of blood Tfh cells was positively correlated with a differentiated B-cell subset in the peripheral blood as well as with SS disease activity. − (Th1-like) subset tended to decrease in blood Tfr cells from pSS patients (statistically not significant, Fig. 4B and C) . Interestingly, the CXCR3 − CCR6 + (Th17-like) subset of blood Tfr cells was higher in pSS patients with hypergammaglobulinemia than those without hypergammaglobulinemia (Fig. 4D) .
Th1-like and Th17-like subsets of blood Tfr cells and hypergammaglobulinemia in SS
As shown previously in Fig. 1B , blood Tfr cells tended to increase in pSS patients. We examined the association of blood Tfr cells and their Th1, Th2, and Th17-like subsets with SS clinical and immunological variables (Fig. 4E) . Blood Tfr cells, particularly CXCR3 + CCR6 − (Th1-like) and CXCR3 − CCR6 + (Th17-like) subsets, were significantly correlated with serum IgG levels in pSS patients ( Fig. 4F and G) . Thus, Th1-like and Th17-like subsets of blood Tfr cells indicate hypergammaglobulinemia in pSS.
DISCUSSION
The present study explored Tfh and Tfr cells and their subsets in the peripheral blood of pSS patients, along with associations with differentiated B-cell subsets, autoantibodies, IL-21 secretion, disease activity score, and target organ inflammation. Since dysregulated B-cell response is a hallmark of pSS, finding blood markers which represent disease activity and autoantibody production could be promising. We found that the CCR7 lo PD-1 hi subset of blood Tfh cells was associated with disease activity score (ESSDAI) and salivary gland inflammation. + T cells are a heterogeneous population that contains both Tfh and Tfr cells. Our study defined circulating Tfh and Tfr cells as distinct populations and found increased proportions of circulating Tfr cells in pSS patients and similar proportions of circulating Tfh cells between patients and HCs. Thus, the ratio of Tfr and Tfh cells was higher in pSS patients than in HCs. This result is consistent with results from other recent studies, which have shown a blood component of Tfr cells in pSS patients (12, 13, 26) . However, the clinical utility of Tfr/Tfh ratio as a blood biomarker in pSS is not clear. One study showed that Tfr/Tfh ratio indicated lymphocytic infiltration in salivary glands of SS, whereas another study using blood samples from larger cohort did not show a correlation between Tfr/Tfh ratio and lymphocytic sialadenitis (12, 13 
CCR7
hi PD-1 lo subset or naïve CD4 + T cells, potently induced plasmablast or plasma cell differentiation and IgG production (21). The CCR7 lo PD-1 hi subset supports rapid and efficient Ab responses in humoral immunity; however, they may play a pathogenic role in autoimmune diseases such as SLE and SS. Our study found that circulating CCR7 lo PD-1 hi Tfh cells could be a biomarker for disease activity and target organ inflammation in SS. Our findings are supported by another study, which demonstrated that blood cell components, such as activated CD4
+ and CD8 + T cells, can be used to divide SS patients into clusters with distinct disease activity and glandular inflammation (27) .
The conflicting results on the correlation of PD-1 and ICOS expression with IL-21 and autoantibodies in pSS showed that PD-1 expression in blood Tfh or Tfr cells is more likely to indicate IL-21 secretion and autoantibody responses in SS. In a study using an SS animal model, CD4 + T cells that had infiltrated mouse lacrimal glands included subsets which highly express PD-1 (28) . Likewise, PD-1 + CD4
+ T cells were abundant in salivary glands from patients with pSS, but were not expressed in the lupus kidney or normal salivary glands (28) . Modulating the lymphotoxin β receptor (LTβR) signaling pathway with LTβR-Ig treatment in non-obese diabetic (NOD) mice had selectively inhibited recruitment of PD-1 -naïve, but PD-1 + effector, T cells to the target organ (28) . This result could explain the negative results of the baminercept (LTβR-Ig) trial in patients with pSS (29) . Thus, we support targeting PD-1-positive cells as an effective treatment strategy for pSS. + T cell subsets in the peripheral blood of juvenile dermatomyositis patients were shifted towards Th2-like and Th17-like cells (19). In the present study, Th2-like and Th17-like subsets of blood Tfh and Tfr cells tended to increase in patients with SS. Another study showed that the Th17-like subset of blood CXCR5 + CD4
+ T cells increased in SS patients and these cells may participate in Ab responses in SS (31). However, the proportions of Th1, Th2, and Th17 subsets were different between circulating Tfh and Tfr cells (32) . Moreover, correlation of Th1, Th2, and Th17 subsets with B-cell function differed between circulating Tfh and Tfr cells in our study, suggesting a different role in indicating autoantibody responses.
We demonstrated that blood Tfr cells, particularly Th1 and Th17 subsets, were correlated with serum IgG levels and hypergammaglobulinemia in SS. Blood Tfr cells, unlike tissue Tfr cells, have limited suppressive capacity on the humoral response, with no impact on IgG and IgA production (11) . Blood Tfr cells leave secondary lymphoid tissues in the immature state and circulate before fully activated into mature GC Tfr cells (11, 14) . Because circulating Tfr cells are increased seven days after vaccination, blood Tfr cells indicate ongoing humoral responses (11, 33) . Therefore, peripheral blood expansion of specific Tfr cell subsets suggests ongoing humoral responses and class-switch recombination in pSS.
In conclusion, blood components of Tfh and Tfr cells reflect disease status of pSS. The CCR7 lo PD-1 hi subset of circulating Tfh cells displays disease activity and glandular inflammation of SS. Subsets of circulating Tfr cells represent ongoing humoral responses in SS. Our findings suggest these blood subsets could be potential pSS biomarkers.
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